Emily Mullin
Medium
Washington, DC, United States
Contact Emily
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Emily:
‘Immunity Passports’ Could Create a New Category of Privilege
Being infected with the virus could come with more freedom. → Read More
Trump’s DNA Is Reportedly For Sale. Here’s What Someone Could Do With It.
The idea isn’t as outlandish as it may seem: An anonymous organization called the Earnest Project is offering the chance to own DNA samples of a handful of world leaders and celebrities. The group… → Read More
Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon
Clinics in Europe say they will continue offering a controversial IVF procedure → Read More
You Can Now Get Your Whole Genome Sequenced for Less Than an iPhone
But will people buy it — and is all that genetic information actually worth it? → Read More
Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind
States in the US have been slow to test newborns for genetic conditions. → Read More
FDA halts one of the first human CRISPR studies before it begins
A trial planning to use the gene-editing tool CRISPR on sickle cell patients has been put on hold due to unspecified questions from US regulators. → Read More
A stem cell transplant in the womb appears to have saved a baby girl’s life
A critically ill fetus that received an infusion of her mother’s stem cells was outwardly healthy when born, suggesting a new way to treat disease before birth. → Read More
Congo aims to stop its Ebola outbreak with an experimental vaccine
For the first time, health officials will use an experimental vaccine in an effort to stop an Ebola outbreak in its early stages. → Read More
Here comes a more precise version of CRISPR
Beam Therapeutics is the first company to go after disease with a more precise genome-editing tool, called base editing. → Read More
Before he died, this biohacker was planning a CRISPR trial in Mexico
Aaron Traywick and his company, Ascendance Biomedical, are connected to a website advertising a gene therapy trial for lung cancer. → Read More
This year, the US government plans to start collecting genetic data from 1 million people
The National Institutes of Health said today that it’s launching a huge research study with the aim of making precision medicine available to people of all backgrounds. → Read More
Billions of dollars are at stake, so the fight over who owns CRISPR is back in court
Credit for a game-changing breakthrough in biotechnology, a potential Nobel prize, and oh yes, gobs of money have proven motive enough for the University of California, Berkeley to keep up its all-but-lost dispute with the Broad Institute of MIT and Harvard over who owns the rights to the gene-editing tool CRISPR. → Read More
These DNA testing companies are mainly trying to sell you other stuff
Beware of tests offering to make “personalized” lifestyle recommendations. → Read More
A worldwide conservation effort aims to sequence the genomes of 1.5 million organisms
Akin to what the Human Genome Project was for medicine, an international group of researchers is launching a massive DNA collection effort called the Earth BioGenome Project to help save endangered species around the world. → Read More
Gene therapy could free some people from a lifetime of blood transfusions
Correcting a genetic mutation lets beta thalassemia patients make healthy blood cells. → Read More
FDA approves AI-powered diagnostic that doesn’t need a doctor’s help
Marking a new era of “diagnosis by software,” the US Food and Drug Administration on Wednesday gave permission to a company called IDx to market an AI-powered diagnostic device for ophthalmology. → Read More
CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys
Monkey studies look encouraging but show there’s still a lot to learn about the gene-editing technology. → Read More
23andMe CEO says consumer genetics will be as normal as at-home pregnancy tests
23andMe CEO and cofounder Anne Wojcicki says consumers don’t need experts to interpret results from genetic risk tests, and compared the information her company offers to at-home pregnancy tests. → Read More
300 genes found at the root of cancers could spur more personalized treatments
A 10-year-long study called the PanCancer Atlas is releasing a trove of genetic data in an effort to help doctors treat a wide variety of cancers more precisely. → Read More
This stem-cell implant could halt an incredibly common cause of blindness
The dream of a stem-cell revolution hasn’t yet materialized—but a small study appears to have used the technology to ward off macular degeneration. → Read More